ArticleFrontiers in oncology2022

Reduced Dose Intensity of Daunorubicin During Remission Induction for Low-Risk Patients With Acute Lymphoblastic Leukemia: A Retrospective Cohort Study of the Chinese Children's Cancer Group.

Yong Zhuang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.